本文翻译正在准备中。在此之前，我们暂时显示英文原文。
商业 · 2012/4/61 分钟阅读
Determination of Regulatory Review Period for Purposes of Patent Extension; VIIBRYD
本地自动翻译 · 来源原始语言
摘要
The Food and Drug Administration (FDA) has determined the regulatory review period for VIIBRYD and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of applications to the Director of Patents and Trademarks, Department of Commerce, for the extension of patents which claim that human drug product.
来源原始语言: Federal Register — Food and Drug Administration打开原始公告 →